利用临床数据与加速度曲线验证气动传输系统
该研究通过健康志愿者标本比较气动传输系统(PTS)与人工转运对溶血和血小板检测的影响,并比较PTS启用前后的历史检验数据。PTS峰值加速度近15 g,人工转运约5 g,但钾、乳酸脱氢酶、血小板功能及活化指标均无差异;历史数据中钾和LD差异有统计学意义但无临床意义。结论为PTS未导致溶血或影响血小板功能,可用HI、钾和LD等结局指标进行质量保证。
要点
- PTS峰值加速度近15 g,远高于人工转运的5 g
- 钾、LD、血小板功能及活化指标在PTS与人工转运间无差异
- PTS启用前后钾和LD差异有统计学意义但无临床意义
核心结论
- 本研究未发现PTS导致溶血或影响血小板功能及活化检测的证据。
- 未发现提示加速度依赖的血液样本质量变化的临床显著改变。
- PTS的质量保证可通过监测HI、钾和LD等结局指标进行。
研究设计与样本
- 从健康志愿者采集重复血样,一份经PTS转运、另一份人工转运至核心实验室。
- 检测溶血标志物(钾、LD、溶血指数)及血小板功能与活化指标。
- 比较PTS实施前后历史溶血标志物检验结果,并用微型g记录仪获取转运加速度曲线。
主要发现
- 人工转运样本最大峰值加速度为5 g,PTS观察到接近15 g的峰值。
- PTS与人工转运间钾、LD、血小板功能及活化结果无差异。
- 历史数据显示三条评估线路的钾和LD在PTS安装前后差异有统计学意义,但估计差异无临床意义。
临床怎么用
- PTS可用于常规血样快速转运,无需担心溶血或血小板功能检测受影响。
- 建议以HI、钾和LD作为PTS质量保证的监测指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Modern pneumatic transportation systems (PTSs) are widely used in hospitals for rapid blood sample transportation. The use of PTS may affect sample integrity. Impact on sample integrity in relation to hemolysis and platelet assays was investigated and also, we wish to outline a process-based and outcome-based validation model for this preanalytical component. Methods The effect of PTS was evaluated by drawing duplicate blood samples from healthy volunteers, one sent by PTS and the other transported manually to the core laboratory. Markers of hemolysis (potassium, lactate dehydrogenase [LD] and hemolysis index [HI]) and platelet function and activation were assessed. Historic laboratory test results of hemolysis markers measured before and after implementation of PTS were compared. Furthermore, acceleration profiles during PTS and manual transportation were obtained from a mini g logger in a sample tube. Results Hand-carried samples experienced a maximum peak acceleration of 5 g, while peaks at almost 15 g were observed for PTS. No differences were detected in results of potassium, LD, platelet function and activation between PTS and manual transport. Using past laboratory data, differences in potassium and LD significantly differed before and after PTS installation for all three lines evaluated. However, these estimated differences were not clinically significant. Conclusions In this study, we found no evidence of PTS-induced hemolysis or impact on platelet function or activation assays. Further, we did not find any clinically significant changes indicating an acceleration-dependent impact on blood sample quality. Quality assurance of PTS can be performed by surveilling outcome markers such as HI, potassium and LD.
引用
- Gils C, Broell F, Vinholt PJ, et al. Use of clinical data and acceleration profiles to validate pneumatic transportation systems. Clin Chem Lab Med. 2020. PMID: 31804954. doi:10.1515/cclm-2019-0881
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。